Baiya Phytopharm Co., Ltd., the first plant-produced biologics company in Southeast. Asia, began the vaccine development from Nicotiana benthamiana leaves

Chula-Baiya COVID-19 vaccine starts human trials

BANGKOK (NNT) – Another potential COVID-19 vaccine developed in Thailand is entering clinical trials, this time a protein subunit vaccine produced from plants by a Thai pharmaceutical startup. If successful, the vaccine is expected to become available in Q3 next year.

Deputy Prime Minister and Minister of Public Health Anutin Charnvirakul, together with the Department of Medical Sciences director and the director of the National Vaccine Institute, has inspected the model plant-based medicines and biological products manufacturing facility, at which a new type of COVID-19 vaccine made from the tobacco plant will be produced.

Full story: National News Bureau of Thailand

Reporter: Tanakorn Sangiam,
Rewriter: Tarin Angskul
National News Bureau of Thailand


The main purpose of Thailand News is to offer our readers all news from the most popular and trusted newspapers in Thailand & Asia in one place.

Get breaking news and the latest news headlines from Bangkok, Phuket, Pattaya, Chiang Mai, Northern Thailand, Isan, the insurgency-plagued South and Asia.

You May Also Like

More From Author

+ There are no comments

Add yours

Leave a Reply